Summary
Several hybridoma cell lines were raised against the highly cytopathic Zairian isolate of Human Immunodeficiency Virus (HIV), HIV1-NDK.
The specificity of the secreted monoclonal antibodies (mAb) was demonstrated by immunoblotting, radioimmunoprecipitation and immunofluorescence. Two hybridoma cell lines secreted mAb reacting with independent epitopes of the NDK p17 capsid protein and its precursors. One, RL16.24.5, is specific for the NDK isolate whereas the other, RL16.45.1, along with anti-p25 RL16.30.1 mAb, bind all HIV1 isolates but not HIV2. Together with the previously described mAb RL4.72.1 those reagents define lentivirus subfamily (HIV1, HIV2, SIV) type/subtype (HIV1) and strain (HIVI-NDK) specific epitopes expressed on HIVl-NDK core proteins. The last mAb RL16.76.1 binds the env gene products gp160 and gp120.
Similar content being viewed by others
References
Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blon C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L: Isolation of a T-lymphotropic retrovirus from patient at risk for acquired immunodeficiency syndrome (AIDS). Science 220: 868–871, 1983
Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, Palker TJ, Redfield, Oleske J, Safai B, White G, Foster P, Markham PD: Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224: 500–503, 1984
Alizon M, Wain-Hobson S, Montagnier L, Sonigo P: Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolated from African patients. Cell 46: 63–74, 1986
Spire B, Sire J, Zachar V, Rey F, Barré-Sinoussi F, Galibert F, Hampe A, Chermann JC: Nucleotide sequence of the HIV-1 NDK: a highly cytopathic strain. Gene 81: 275–284, 1989
Clavel F, Guetard D, Brun-Vezinet F, Chamaret S,Rey MA, Santos-Ferreira O, Laurent AG, Dauguet C, Katlama C, Rouzioux C, Klatzmann D, Champalimalid JL, Montagnier L: Isolation of a new human retrovirus from West-Africa patients with AIDS. Science 223: 343–346, 1986
Guyader M, Emerman M, Sonigo P, Clavel F, Alizon M: Genome organization and transactivation of the human immunodeficiency virus type 2. Nature 326: 662–669, 1987
Daniel MD, Letvin NL, King NW, Kannagi M, Sehgal PK, Hunt RD, Kanki PJ, Essex M, Desrosiers RC: Isolation of T-cell tropic HTLV-III Like Retrovirus from Macaques. Science 228: 1201–1204, 1985
Ohta Y, Masuda T, Tsujimoto H, Ishikawa KI, Kodama T, Morikawa S, Nakai M, Honjo S, Hayami M: Isolation of Simian Immunodeficiency Virus from Africa Green Monkeys and seroepidemiology survey of the virus in various non human primates. Int J Cancer 41: 115–122, 1988
Asjo B, Albert J, Karlsson A, Morfeldt-Manson L, Biberfeld G, Lidman K, Fenyo EM: Replicative properties of human immunodeficiency virus from patient with varying severity of HIV infection. Lancet II: 660–662, 1986
Anand R, Reed C, Forlenza S, Siegal F, Cheungt, Moore J: Non-cytocidal natural variants of human immunodeficiency virus isolated from AIDS patients with neurological disorder. Lancet 11: 234–238, 1987
Evans LA, Mc Hugh TM, Stites DP, Levy JA: Differential ability of HIV isolates to productively infect human cells. J Immunol 138: 3415–3418, 1987
Cordonnier A, Montagnier L, Emerman M: Single aminoacid changes in HIV envelope affect viral tropism and receptor binding. Nature 340: 571–574, 1989
Mc Keating JA, Gow J, Goudsmit J, Pearl LH, Mulder C, Weiss R: Characterization of HIV1 neutralization escape mutants. AIDS 3: 777–784, 1989
Ferns RB, Tedder RS, Weiss RA: Characterization of monoclonal antibody against the human immunodeficiency virus (HIV) gag products and their used in monitoring HIV isolate variation. J Gen Virol 68: 1543–1551, 1987
Minassian AA, Kalyanaraman VS, Gallo RC, Popovic M: Monoclonal antibodies against human immunodeficiency virus (HIV) type 2 core proteins; Cross-reactivity with HIV type 1 and simian immunodeficiency virus. Proc Natl Acad Sci (USA) 85: 6939–6943, 1988
Niedrig M, Rabanus JP, L'Agestehr J, Gelderblom HR, Pauli G: Monoclonal antibodies directed against Human Immunodeficiency Virus (HIV) gag proteins with specificity for conserved epitopes in HIV-1, HIV-2 and Simian Immunodeficiency Virus. J Gen Virol 69: 2031–2036, 1988
Tersmette M, Winkel IN, Groenink M, Gruters RA, Spence RP, Saman E, Van der Green G, Miedema F, Huisman JG: Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV p24 gag. Virology 171: 149–155, 1989
Tatsumi M, Devaux C, Kourilsky F, Chermann JC: Characterization of monoclonal antibodies directed against distinct conserved epitopes of Human Immunodeficiency virus type 1 core proteins. Mol Cell Biochem. 96: 127–136, 1990
Pierres M, Devaux C, Dosseto M, Marchetto S: Clonal Analysis of B and T cell responses to Ia Antigens I — Topology of epitope regions on IAK and IEK molecules analyzed with 35 monoclonal alloantibodies. Immunogenetics 14: 481–495, 1981
Ellrodt A, Le Bras Ph, Brun-Vezinet F, Segond P, Montagnier L, Barré-Sinoussi F, Nugeyre MT, Rey F, Rouzioux C, Caquet R, Chermann JC: Isolation of a human T lymphotropic retrovirus (LAV) from Zaïrian married couple, one with AIDS, one with prodomes. Lancet i: 1383–1385, 1984
Galfre G, Howe SC, Milstein C, Butcher GW, Howard JC: Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature 266: 550–552, 1977
Kearney JF, Radbruck A, Liesegang B, Rajewsky K: A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody secreting hybrid cell line. J Immunol 123: 1548–1550, 1979
Frazekas de St Groth S, Scheideffer D: Production of monoclonal antibodies: strategy and tactics. J Immunol Methods 35: 1–22, 1980
Devaux C, Nadler PI, Miller GG, Sachs DH: Genetic control of immune response to staphylococcal nuclease. XII: Analysis of nuclease antigenic determinants using antinuclease monoclonal antibodies. Mol Cell Biochem 68: 31–40, 1985
Asano M, Morikawa S, Tatsumi M, Ohta Y, Ishikawa KI, Ushijima H, Hayami M, Kitamura T: Common epitopes on gag proteins of HIV-1 and SIV (AGM) using monoclonal antibodies. (Abst). IV Int Conf on AIDS, 1988
Laemli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–683, 1970
Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci (USA) 76: 4350–4354, 1979
Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MP, Weiss RA: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763–767, 1984
Smith DH, Byrn RA, Masters SA, Gregory T, Groopman JE, Capon DJ: Blocking of HIV-1 infectivity by a soluble, secreted form of CD4 antigen. Science 238: 1704–1707, 1987
Willey RL, Smith DH, Lasky LA, Theodore TS, Earl PL, Moss B, Capon DJ, Martin MA: In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol 62: 139–144, 1988
Ho DD, Sarngadharan MG, Hirsch MS, Schooley RT, Rota TR, Kennedy RC, Chanh TC, Sato VL: Human Immuno-deficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins. J Virol 61: 2024–2029, 1987
Gosting LH, Mc Clare J, Dickison ES, Watanabe SM, Shriver K, Goldstein LC: Monoclonal antibodies to gp110 and gp41 of Human Immunodeficiency virus. J Clin Microbiol 25: 845–848, 1987
Bahraoui E, Clerget-Raslain B, Chapuis F, Olivier R, Parravicini C, Yagello M, Montagnier L, Gluckman JC: A molecular mechanism of inhibition of HIV1 binding to CD4+ cells by monoclonal antibodies to gp110. AIDS 2: 165–169, 1988
Thiriart C, Francotte M, Cohen J, Collignon C, Delers A, Kummert S, Molitor C, Gilles D, Roelants P, Van Wijnendaele F, De Wilde M, Bruck C: Several antigenic determinants exposed on the gp120 moiety of HIV-1 gp160 are hidden on the mature gp120. J Immunol 143: 1832–1836, 1989
Rusche JR, Javaherian K, Mc Danal C, Petro J, Lynn DL, Grimaila R, Langlois A, Gallo RC, Arthur LO, Fischinger PJ, Bolognesi DP, Putney SD, Matthews TJ: Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc Natl Acad Sci USA 85: 3198–3202, 1988
Meloen RH, Liskamp RM, Goudsmit J: Specificity and function of the individual amino acids of an important determinant of Human Immunodeficiency virus type 1 that induces neutralizing activity. Gen Virol 70: 1505–1512, 1989
Papsidero LD, Sheu M, Ruscetti FW: Human Immunodeficiency virus type 1 — Neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping. Virol 63: 267–272, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Robert, V., Resnicoff, M., Chermann, JC. et al. Characterization of monoclonal antibodies identifying type and strain-specific epitopes of human immunodeficiency virus type 1. Mol Cell Biochem 102, 115–123 (1991). https://doi.org/10.1007/BF00234569
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00234569